Research programme: angiogenesis inducing therapeutics - MedPacto
Latest Information Update: 13 Jun 2014
At a glance
- Originator MedPacto
- Mechanism of Action Angiogenesis inducing agents; Wnt protein stimulants; Wnt signalling pathway stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Ischaemia; Myocardial infarction
Most Recent Events
- 13 Jun 2014 Early research in Myocardial infarction in South Korea (unspecified route)
- 13 Jun 2014 Early research in Ischaemia in South Korea (unspecified route)